Company intelligence / Profile preview
Tillomed
Luton, Bedfordshire, United Kingdomtillomed.com ↗
- Ownership
- Private
- Employees
- ~77
- Development stage
- Other
01
Overview
Tillomed markets over 100 generic pharmaceutical products across multiple dosage forms and therapeutic areas in Europe. The company has grown significantly since its acquisition by Emcure, expanding its product portfolio and European presence. No proprietary clinical results as it focuses on generics.
- Therapeutic areas
- Infectious DiseasesCardiovascularOncologyNeurology
- Modalities
- Small moleculeGeneric pharmaceuticals
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Tillomed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tillomed.